- Acquired by ZOLL Medical for $538M, Sep 2021
- Went public, Feb 2007
- Acquired Spry Health, Jan 2021
About
Itamar Medical is a medical device company focused on the integration of sleep apnea management into the cardiac patient care pathway. The companys core strategies include the development, manufacture, and sale of the FDA-cleared WatchPAT diagnostic product line. The WatchPAT line is based on the biological PAT signal acquired by the PAT technology, which is proven as a simple, comprehensive, reliable, and scalable alternative to airflow as well as enabling point-of-deployment versatility; and Total Sleep Solutions, a product that includes a field support organization, partnerships, and core and supporting technologies that enable all physicians, and cardiologists in particular, to provide a seamless and full continuum of care to sleep apnea patients as part of their care pathway. In addition, the company has developed and is currently marketing the EndoPAT system, an endothelial function assessment tool for risk classification used by clinicians, researchers, and pharmaceutical companies to easily and reliably quantify and track arterial health. In recent years, Itamar Medical has signed a number of strategic marketing agreements for its products, including agreements with Medtronic, Philips, Resmed, and SoClean in the U.S. and Philips Respironics in Japan.
Funding history · 8 rounds · $260.4M total
Q&A
- What is Itamar Medical's primary business focus?
- Itamar Medical is a medical device company that focuses on integrating sleep apnea management into the cardiac patient care pathway. They develop, manufacture, and sell the FDA-cleared WatchPAT diagnostic product line and the EndoPAT system for endothelial function assessment.
- When was Itamar Medical acquired and by whom?
- Itamar Medical was acquired by ZOLL Medical in September 2021 for $538,000,000.
- What is the total amount of funding Itamar Medical raised before its acquisition?
- Itamar Medical raised a total of $260,450,000 in funding.
- Which investors participated in Itamar Medical's PIPE round in February 2020?
- The PIPE round in February 2020 was led by Ally Bridge Group.
- What was Itamar Medical's last public offering amount and date?
- Itamar Medical had a public offering in February 2021, raising $70,000,000.
- How many employees does Itamar Medical have?
- Itamar Medical has 201-500 employees.
- What strategic marketing agreements has Itamar Medical signed for its products?
- Itamar Medical has signed strategic marketing agreements with companies such as Medtronic, Philips, Resmed, and SoClean in the U.S., and Philips Respironics in Japan.
- What is the core technology behind Itamar Medical's WatchPAT diagnostic product line?
- The WatchPAT line is based on the biological PAT signal acquired by PAT technology, which provides a simple, comprehensive, reliable, and scalable alternative to airflow for sleep apnea diagnosis.
Team · 6
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | itamar-medical.com |
|---|---|
| linkedin.com/company/52332 | |
| facebook.com/ItamarMedical | |
| YouTube | youtube.com/channel/UCp9BVLvc1Fvh1z7NsbPI_ZA |
| Wikipedia | en.wikipedia.org/wiki/Itamar_Medical |
| Wikidata | wikidata.org/wiki/Q50038825 |
Identifiers & details
| Founded | 1997-1 |
|---|---|
| Employees (exact) | 330 |
| Offices | Atlanta; Amsterdam; Minato |
| Status reason | Acquired by ZOLL Medical on Sep, 2021 |
| Wikidata QID | Q50038825 |
Acquisitions & public offerings
Acquired by ZOLL Medical 2021-09 $538.0M
| Acquired | Date | Amount |
|---|---|---|
| Spry Health | 2021-01 |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2007-02 | ||||
| 2019-02 | ||||
| 2021-02 | $70.0M | |||
| 2021-12 |
Radar intelligence
Patents
| EPO | 35 |
|---|
Web history (Wayback)
| Domain | itamar-medical.com |
|---|
Wikidata
| QID | Q50038825 |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|